معرفی
Shentong Fang serves as Supervisor for the Doctoral Programme in Biomedicine at the University of Helsinki's Faculty of Medicine, Department of Biomedicine. With 17 total publications spanning 2011-2023, their research bridges vascular biology, immunology, and oncology.
Research focuses on lymphatic vessel function (particularly VEGFR3 signaling in neuroinflammation), cardiovascular pathophysiology (Tie2 receptor mechanisms in atherosclerosis), and cancer microenvironment dynamics (intestinal adenoma development and immunogenic cell death). Key methodologies include in vivo vascular modeling and molecular pathway analysis.
Recent publications in Science Immunology (2023) and Nature Cardiovascular Research (2023) demonstrate leadership in vascular signaling research. The 2021 eLife study on cardiac endothelial senescence reveals mechanistic links between cardiovascular risk factors and cellular aging.
As doctoral programme supervisor, Fang mentors emerging researchers in biomedicine. Collaborative networks include Kari Alitalo's lab (lymphatic research) and international teams across immunology and cardiovascular fields.
Active in the University of Helsinki's biomedical research ecosystem, Fang contributes to cross-disciplinary projects investigating vascular-immune interactions in disease contexts.
